- Home
- ILAG vs SHPH Comparison
ILAG vs SHPH Comparison
Compare ILAG & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- SHPH
- Stock Information
- Founded
- ILAG 1981
- SHPH 2012
- Country
- ILAG Hong Kong
- SHPH United States
- Employees
- ILAG N/A
- SHPH N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- ILAG Consumer Discretionary
- SHPH Health Care
- Exchange
- ILAG Nasdaq
- SHPH Nasdaq
- Market Cap
- ILAG 18.4M
- SHPH 3.3M
- IPO Year
- ILAG 2022
- SHPH 2022
- Fundamental
- Price
- ILAG $0.98
- SHPH $1.41
- Analyst Decision
- ILAG
- SHPH
- Analyst Count
- ILAG 0
- SHPH 0
- Target Price
- ILAG N/A
- SHPH N/A
- AVG Volume (30 Days)
- ILAG 47.1K
- SHPH 43.1K
- Earning Date
- ILAG 11-29-2024
- SHPH 11-12-2024
- Dividend Yield
- ILAG N/A
- SHPH N/A
- EPS Growth
- ILAG N/A
- SHPH N/A
- EPS
- ILAG N/A
- SHPH N/A
- Revenue
- ILAG $6,443,357.00
- SHPH N/A
- Revenue This Year
- ILAG N/A
- SHPH N/A
- Revenue Next Year
- ILAG N/A
- SHPH N/A
- P/E Ratio
- ILAG N/A
- SHPH N/A
- Revenue Growth
- ILAG N/A
- SHPH N/A
- 52 Week Low
- ILAG $0.33
- SHPH $1.03
- 52 Week High
- ILAG $1.35
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- ILAG 44.56
- SHPH 49.84
- Support Level
- ILAG $0.97
- SHPH $1.12
- Resistance Level
- ILAG $1.06
- SHPH $1.26
- Average True Range (ATR)
- ILAG 0.06
- SHPH 0.11
- MACD
- ILAG -0.01
- SHPH 0.06
- Stochastic Oscillator
- ILAG 16.32
- SHPH 68.09
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.